3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Prostatic Neoplasms
1
Neuroendocrine Tumors
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Dexamethasone
13
Bevacizumab
9
Saline Solution
8
Bupivacaine
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
Fluorouracil
7
pembrolizumab
6
Rituximab
6
Prednisone
6
Letrozole
6
Cisplatin
6
Carboplatin
6
Sodium Chloride
5
Ropivacaine
5
Propofol
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
trametinib
4
lenvatinib
4
dabrafenib
4
cabozantinib
4
anlotinib
4
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neuropsychological Tests
×
1 year
×
Clear all
NCT04373564
2026-01-22
ODYSSEY
Guerbet
Phase 4
Recruiting
2,076 enrolled